Secondary Logo

Institutional members access full text with Ovid®

In patients with uncontrolled type 2 diabetes, are GLP-1 agonists more effective than SGLT-2 inhibitors in lowering HbA1c?

Johnson, Stuart K., DO; Bidle, David, MD; O'Connor, Christopher, MD, MPH; Van Antwerp, Jason, MD

doi: 10.1097/01.EBP.0000544890.57703.2b

Marquette FMRP, Marquette, MI

The authors declare no conflicts of interest.

© Copyright 2018 Family Physicians Inquiries Network, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website